Literature DB >> 27480391

Molecular epidemiology of junctional epidermolysis bullosa: discovery of novel and frequent LAMB3 mutations in Chilean patients with diagnostic significance.

I Fuentes1,2, M Campos2, G Repetto2, P Morandé1, M J Yubero1,3, S Gonzalez4, A Klausegger5, P Schnitzhofer5, G Pohla-Gubo5, J Bauer5, F Palisson1,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27480391     DOI： 10.1111/bjd.14920

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  4 in total

1.  LAMB3 mediates apoptotic, proliferative, invasive, and metastatic behaviors in pancreatic cancer by regulating the PI3K/Akt signaling pathway.

Authors:  Hong Zhang; Yao-Zhen Pan; May Cheung; Mary Cao; Chao Yu; Ling Chen; Lei Zhan; Zhi-Wei He; Cheng-Yi Sun
Journal:  Cell Death Dis       Date:  2019-03-08       Impact factor: 8.469

2.  Clinical practice guidelines for laboratory diagnosis of epidermolysis bullosa.

Authors:  C Has; L Liu; M C Bolling; A V Charlesworth; M El Hachem; M J Escámez; I Fuentes; S Büchel; R Hiremagalore; G Pohla-Gubo; P C van den Akker; K Wertheim-Tysarowska; G Zambruno
Journal:  Br J Dermatol       Date:  2019-08-09       Impact factor: 9.302

3.  Epidermolysis Bullosa in Chinese Patients: Genetic Analysis and Mutation Landscape in 57 Pedigrees and Sporadic Cases.

Authors:  Yueqian Yu; Zhenzhen Wang; Zihao Mi; Lele Sun; Xi'an Fu; Gongqi Yu; Zheng Pang; Hong Liu; Furen Zhang
Journal:  Acta Derm Venereol       Date:  2021-07-15       Impact factor: 3.875

4.  Laminin‑332 mediates proliferation, apoptosis, invasion, migration and epithelial‑to‑mesenchymal transition in pancreatic ductal adenocarcinoma.

Authors:  Caiqun Huang; Jun Chen
Journal:  Mol Med Rep       Date:  2020-11-12       Impact factor: 2.952
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.